Hyeon A. Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hyeon A. Kim has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Joo Yeon Kim
Department of Cardiovascular and Thoracic Surgery, Ewha Womans University Medical Center, Seoul, Republic of Korea
2 shared publications M.D.
2 shared publicationsPh.D.
2 shared publications- Pyo Won Park
Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 shared publications - Wook Sung Kim
Department of Thoracic and Cardiovascular Surgery, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 shared publications - Young Su Kim
Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by Editorial Committee of Annals of Thoracic and Cardiovascular Surgery in Annals of Thoracic and Cardiovascular Surgery
- Vol. 31 (1)
Posterior Leaflet Overlay Patch Reinforcement for Mitral Valve Posterior Tethering: The Elbow Patch Repair
The scarcity of leaflet tissue and restricted systolic motion remain challenges in mitral valve repair. In addition to functional or secondary mitral regurgitation, atrial functional mitral regurgitation, characterized by chronic atrial fibrillation, preserved left ventricular function, and atriogenic leaflet tethering, exacerbates leaflet scarcity, complicating mitral valve repair. To address this, we introduce the “elbow patch repair,” a novel technique using an autologous pericardium overlay patch to reinforce the posterior mitral valve leaflet. A 65-year-old male patient with chronic atrial fibrillation and severe mitral regurgitation consistent with atrial functional mitral regurgitation underwent the “elbow patch repair” combined with annuloplasty and neochordae placement. This approach effectively managed posterior mitral valve leaflet deficiency and restored the coaptation surface. The “elbow patch repair” offers a straightforward and effective solution for leaflet shortage in atrial functional mitral regurgitation and select cases of Carpentier Class IIIb. Further studies are needed to assess its long-term durability.
- 1 January 2025
- Published by Editorial Committee of Annals of Thoracic and Cardiovascular Surgery in Annals of Thoracic and Cardiovascular Surgery
- Vol. 31 (1)
Open AccessPosterior Leaflet Overlay Patch Reinforcement for Mitral Valve Posterior Tethering: The Elbow Patch Repair
The scarcity of leaflet tissue and restricted systolic motion remain challenges in mitral valve repair. In addition to functional or secondary mitral regurgitation, atrial functional mitral regurgitation, characterized by chronic atrial fibrillation, preserved left ventricular function, and atriogenic leaflet tethering, exacerbates leaflet scarcity, complicating mitral valve repair. To address this, we introduce the “elbow patch repair,” a novel technique using an autologous pericardium overlay patch to reinforce the posterior mitral valve leaflet. A 65-year-old male patient with chronic atrial fibrillation and severe mitral regurgitation consistent with atrial functional mitral regurgitation underwent the “elbow patch repair” combined with annuloplasty and neochordae placement. This approach effectively managed posterior mitral valve leaflet deficiency and restored the coaptation surface. The “elbow patch repair” offers a straightforward and effective solution for leaflet shortage in atrial functional mitral regurgitation and select cases of Carpentier Class IIIb. Further studies are needed to assess its long-term durability.
- Open Access
- 6 April 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-10
Missed postoperative metabolic acidosis associated with sodium-glucose transporter 2 inhibitors in cardiac surgery patients: a retrospective analysis
The increasing use of sodium glucose transporter 2 inhibitors (SGLT2i) for treating cardiovascular (CV) diseases and type 2 diabetes (T2D) is accompanied by a rise in euglycemic diabetic ketoacidosis occurrences in cardiac surgery patients. Patients undergoing cardiac surgery, due to their pre-existing CV disease which often requires SGLT2i prescriptions, face an increased risk of postoperative metabolic acidosis (MA) or ketoacidosis (KA) associated with SGLT2i, compounded by fasting and surgical stress. The primary aim of this study is to quantify the incidence of SGLT2i-related postoperative MA or KA and to identify related risk factors. We analyzed data retrospectively of 823 cardiac surgery patients, including 46 treated with SGLT2i from November 2019 to October 2022. Among 46 final cohorts treated preoperatively with SGLT2i, 29 (63%) developed postoperative metabolic complications. Of these 46 patients, stratified into two categories based on postoperative laboratory findings, risk factor analysis were conducted and compared. Analysis indicated a prescription duration over one week significantly elevated the risk of complications (Unadjusted OR, 11.7; p = 0.032*; Adjusted OR, 31.58; p = 0.014*). A subgroup analysis showed that a cardiopulmonary bypass duration of 60 min or less significantly raises the risk of SGLT2i-related postoperative MA in patients with a sufficient prescription duration. We omitted the term "diabetes" in describing complications related to SGLT2i, as these issues are not exclusive to T2D patients. Awareness of SGLT2i-related postoperative MA or KA can help clinicians distinguish between non-life-threatening conditions and severe causes, thereby preventing unnecessary tests and ensuring best practice.
- 6 April 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-10
Open AccessMissed postoperative metabolic acidosis associated with sodium-glucose transporter 2 inhibitors in cardiac surgery patients: a retrospective analysis
The increasing use of sodium glucose transporter 2 inhibitors (SGLT2i) for treating cardiovascular (CV) diseases and type 2 diabetes (T2D) is accompanied by a rise in euglycemic diabetic ketoacidosis occurrences in cardiac surgery patients. Patients undergoing cardiac surgery, due to their pre-existing CV disease which often requires SGLT2i prescriptions, face an increased risk of postoperative metabolic acidosis (MA) or ketoacidosis (KA) associated with SGLT2i, compounded by fasting and surgical stress. The primary aim of this study is to quantify the incidence of SGLT2i-related postoperative MA or KA and to identify related risk factors. We analyzed data retrospectively of 823 cardiac surgery patients, including 46 treated with SGLT2i from November 2019 to October 2022. Among 46 final cohorts treated preoperatively with SGLT2i, 29 (63%) developed postoperative metabolic complications. Of these 46 patients, stratified into two categories based on postoperative laboratory findings, risk factor analysis were conducted and compared. Analysis indicated a prescription duration over one week significantly elevated the risk of complications (Unadjusted OR, 11.7; p = 0.032*; Adjusted OR, 31.58; p = 0.014*). A subgroup analysis showed that a cardiopulmonary bypass duration of 60 min or less significantly raises the risk of SGLT2i-related postoperative MA in patients with a sufficient prescription duration. We omitted the term "diabetes" in describing complications related to SGLT2i, as these issues are not exclusive to T2D patients. Awareness of SGLT2i-related postoperative MA or KA can help clinicians distinguish between non-life-threatening conditions and severe causes, thereby preventing unnecessary tests and ensuring best practice.
- Open Access
- 14 August 2023
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 56 (5) , 295-303
Losartan Reduces Remodeling and Apoptosis in an Adriamycin-Induced Cardiomyopathy Rat Model
Hyeon A Kim, M.D., Kwan Chang Kim, M.D., Ph.D., Hyeryon Lee, Ph.D., Young Mi Hong, M.D., Ph.D.. J Chest Surg 2023;56:295-303. https://doi.org/10.5090/jcs.23.044
- 14 August 2023
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 56 (5) , 295-303
Open AccessLosartan Reduces Remodeling and Apoptosis in an Adriamycin-Induced Cardiomyopathy Rat Model
Hyeon A Kim, M.D., Kwan Chang Kim, M.D., Ph.D., Hyeryon Lee, Ph.D., Young Mi Hong, M.D., Ph.D.. J Chest Surg 2023;56:295-303. https://doi.org/10.5090/jcs.23.044
- Open Access
- 16 March 2023
- Published by Elsevier in JTCVS Techniques
- Vol. 19, 125-127
Purely bilateral internal thoracic artery bypass grafting in a child with multivessel coronary involvement of Kawasaki disease
- 16 March 2023
- Published by Elsevier in JTCVS Techniques
- Vol. 19, 125-127
Open AccessPurely bilateral internal thoracic artery bypass grafting in a child with multivessel coronary involvement of Kawasaki disease
- Open Access
- 5 April 2021
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 54 (2) , 150-153
Intractable Coronary Spasm Requiring Percutaneous Coronary Intervention after Coronary Artery Bypass Grafting in a Patient with Moyamoya Disease
Hyeon A Kim, M.D., Young Su Kim, M.D., Wook Sung Kim, M.D., Ph.D.. Korean Journal of Thoracic and Cardiovascular Surgery 2021;54:150-3. https://doi.org/10.5090/jcs.20.058
- 5 April 2021
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 54 (2) , 150-153
Open AccessIntractable Coronary Spasm Requiring Percutaneous Coronary Intervention after Coronary Artery Bypass Grafting in a Patient with Moyamoya Disease
Hyeon A Kim, M.D., Young Su Kim, M.D., Wook Sung Kim, M.D., Ph.D.. Korean Journal of Thoracic and Cardiovascular Surgery 2021;54:150-3. https://doi.org/10.5090/jcs.20.058
- Open Access
- 5 February 2021
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 54 (1) , 17-24
Implementation of Venoarterial Extracorporeal Membrane Oxygenation in Nonintubated Patients
Hyeon A Kim, M.D., Young Su Kim, M.D., Yang Hyun Cho, M.D., Ph.D., Wook Sung Kim, M.D., Ph.D., Kiick Sung, M.D., Ph.D., Dong Seop Jeong, M.D., Ph.D.. J Chest Surg 2021;54:17-24. https://doi.org/10.5090/kjtcs.20.070
- 5 February 2021
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 54 (1) , 17-24
Open AccessImplementation of Venoarterial Extracorporeal Membrane Oxygenation in Nonintubated Patients
Hyeon A Kim, M.D., Young Su Kim, M.D., Yang Hyun Cho, M.D., Ph.D., Wook Sung Kim, M.D., Ph.D., Kiick Sung, M.D., Ph.D., Dong Seop Jeong, M.D., Ph.D.. J Chest Surg 2021;54:17-24. https://doi.org/10.5090/kjtcs.20.070